H
UNT VALLEY, Md.--Oxford Molecular Group has launched OMMM 2.0, designed for use by biologists, pharmacologists, and research managers in the drug discovery screening environment. OMMM, the desktop-component of Oxford’s Oracle-based system for enterprisewide and smaller screening operations and workgroups, is a flexible tool that can be configured to meet specific lab needs, said the company. The new release has enhanced tools for data analysis and features to enable easier use and greater levels of automation and customization.